Evidence map›Paper›PMID 42091052›Full record

Trial reportAddiction (Abingdon, England)2026

Efficacy and safety of transcranial direct current stimulation in alcohol use disorder: A randomized controlled triple-blind trial.

Benoit Trojak, Anne Sauvaget, Wissam El Hage, Thomas Wallenhorst, Benjamin Rolland, Philippe Nubukpo, Ghina Harika-Germaneau, David Szekely, Julie Giustiniani, Marc Auriacombe and 10 more

Abstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Addiction (Abingdon, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Benoit TrojakService Hospitalo-Universitaire d'Addictologie, Université Bourgogne Europe, CHU Dijon Bourgogne, Dijon, France.
Anne SauvagetMouvement, Interactions, Performance, MIP, UR 4334, Nantes Université, CHU Nantes, Nantes, France.
Wissam El HageCHRU de Tours, Clinique Psychiatrique Universitaire, Tours, France.
Thomas WallenhorstService de Psychiatrie Adultes et Addictologie, CH Semur-en-Auxois, Semur-en-Auxois, France.
Benjamin RollandService Universitaire d'Addictologie de Lyon (SUAL), Hospices Civils de Lyon, CH Le Vinatier, Lyon France unité PSR2, CRNL, UMR 5292 CNRS/1028 INSERM - Université Lyon 1, Bron, France.
Philippe NubukpoInserm U1094, IRD UMR270, Université de Limoges, CHU Limoges, EpiMaCT, Limoges, France.
Ghina Harika-GermaneauCeRCA, CNRS, Université de Poitiers, Université de Tours, Poitiers, France.
David SzekelyService de Psychiatrie, Centre Hospitalier Princesse Grace, Monaco.
Julie GiustinianiUMR INSERM 1322 LINC, Université de Franche Comté, Besançon, France.
Marc AuriacombeSANPSY, CNRS UMR 6033, Université de Bordeaux, Bordeaux, France.ORCID https://orcid.org/0000-0002-8938-8683
Georges BrousseService de Psychiatrie Adulte et d'Addictologie, CHU Clermont-Ferrand CNRS, Université Clermont-Auvergne, Institut Pascal, Clermont-Ferrand, France.
Sébastien GuillaumeService Urgence et Post-Urgence Psychiatrique, Hôpital Lapeyronie, CHRU, Montpellier, France.
Maxime BubrovszkyFédération Régionale de Recherche en Santé Mentale et Psychiatrie, Hauts-de-France, France.
Benjamin PetitService Hospitalo-Universitaire d'Addictologie, Université Bourgogne Europe, CHU Dijon Bourgogne, Dijon, France.ORCID https://orcid.org/0000-0001-6670-7920
Clémence CabelguenAddiction Medicine and Psychiatry Department, Nantes Université, CHU Nantes, Nantes, France.ORCID https://orcid.org/0000-0001-6042-5826
Hussein El AyoubiCHRU de Tours, Clinique Psychiatrique Universitaire, Tours, France.
Suzanne RankinDirection de la Recherche Clinique et de l'Innovation, Unité de Soutien Méthodologique à la Recherche, CHU Dijon Bourgogne, Dijon, France.
Agnès Soudry-FaureDirection de la Recherche Clinique et de l'Innovation, Unité de Soutien Méthodologique à la Recherche, CHU Dijon Bourgogne, Dijon, France.
Karine GoueslardDirection de la Recherche Clinique et de l'Innovation, Unité de Soutien Méthodologique à la Recherche, CHU Dijon Bourgogne, Dijon, France.
Anastasia DeminaService Hospitalo-Universitaire d'Addictologie, Université Bourgogne Europe, CHU Dijon Bourgogne, Dijon, France.ORCID https://orcid.org/0000-0001-7694-6618

Funding

French Ministry of Health PHRC 2015-A00576-43Scientific Center of Monaco 06-2015
6 · The paper itself

Abstract

BACKGROUND AND

aimsCurrent treatment options for alcohol use disorder are limited. Transcranial direct current stimulation has been proposed as a therapeutic approach, but evidence remains scarce. This study aimed to compare active vs. sham transcranial direct current stimulation to evaluate its efficacy and safety in reducing alcohol consumption in a large sample of individuals with alcohol use disorder.

designREDSTIM is a triple-blind, randomized, sham-controlled trial that was conducted from October 2015 to January 2022. Participants were followed up every 4 weeks for 24 weeks.

settingFourteen sites in France and Monaco.

participants356 adult outpatients with alcohol use disorder were assessed for eligibility, and 337 were enrolled and randomly assigned (1:1) to receive active or sham stimulation. At baseline, the randomized participants were primarily male (60.5%) with an average age of 51.3 ± 11.3 years. INTERVENTION AND COMPARATOR: Two daily stimulation sessions (anode F4, cathode F3, 2 mA) delivered over five consecutive days vs. sham stimulation. Direct currents were applied via a pair of 0.9% NaCl-soaked surface sponge electrodes (25 cm MEASUREMENTS: The co-primary outcomes were the change in the number of heavy drinking days (HDD) and total alcohol consumption (TAC) over the follow-up period. Exploratory secondary outcomes included alcohol craving, clinical and biological improvements, quality-of-life, mood, cognitive and safety assessments.

findingsOver 24 weeks of follow-up, vs. sham, the active stimulation group reported statistically significant reductions in the number of HDD [-2.45 HDD/4 weeks, 97.5% confidence interval (CI) = -4.86 to -0.05, P = 0.022]. The reduction in TAC was not statistically significant (-5.96 g/day, 97.5% CI = -15.18 to 3.26, P = 0.147). The interpretation of these findings should take into account the proportion of missing data related to alcohol diary completeness and losses to follow-up. For secondary outcomes at 24 weeks, vs. sham, craving assessments were lower in the stimulation group (-0.36 95% CI = -0.65 to -0.07, P = 0.016), as were carbohydrate deficient transferrin levels (-0.33 95% CI = -0.65 to -0.01, P = 0.045). In the active vs. sham stimulation group, 69 (41.1%) and 62 participants (36.7%) experienced one or more adverse effects, resulting in 6 dropouts.

conclusionsAmong adult outpatients with alcohol use disorder, active transcranial direct current stimulation resulted in a modest but sustained reduction in heavy drinking days over 24 weeks, while no statistically significant effect was observed for total alcohol consumption. The intervention was well tolerated.

Indexed as

AlcoholismTranscranial Direct Current StimulationAdultCravingFemaleFranceHumansMaleMiddle AgedTreatment Outcomealcohol use disorderefficacyheavy drinking daysrandomized controlled trialsafetytotal alcohol consumptiontranscranial direct current stimulation

Identifiers

PMID42091052
PMCPMC13357871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.